This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Bionano Genomics Gestione
Gestione criteri di controllo 2/4
Bionano Genomics' CEO is Robert Holmlin, appointed in Jan 2011, has a tenure of 12.83 years. total yearly compensation is $2.77M, comprised of 19.7% salary and 80.3% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth €66.79K. The average tenure of the management team and the board of directors is 1.8 years and 4.5 years respectively.
Informazioni chiave
Robert Holmlin
Amministratore delegato
US$2.8m
Compenso totale
Percentuale dello stipendio del CEO | 19.7% |
Mandato del CEO | 12.8yrs |
Proprietà del CEO | 0.1% |
Durata media del management | 1.8yrs |
Durata media del Consiglio di amministrazione | 4.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2023 | n/a | n/a | -US$147m |
Mar 31 2023 | n/a | n/a | -US$140m |
Dec 31 2022 | US$3m | US$544k | -US$133m |
Sep 30 2022 | n/a | n/a | -US$117m |
Jun 30 2022 | n/a | n/a | -US$106m |
Mar 31 2022 | n/a | n/a | -US$92m |
Dec 31 2021 | US$8m | US$484k | -US$72m |
Sep 30 2021 | n/a | n/a | -US$61m |
Jun 30 2021 | n/a | n/a | -US$51m |
Mar 31 2021 | n/a | n/a | -US$41m |
Dec 31 2020 | US$708k | US$376k | -US$41m |
Sep 30 2020 | n/a | n/a | -US$37m |
Jun 30 2020 | n/a | n/a | -US$33m |
Mar 31 2020 | n/a | n/a | -US$32m |
Dec 31 2019 | US$899k | US$404k | -US$30m |
Sep 30 2019 | n/a | n/a | -US$28m |
Jun 30 2019 | n/a | n/a | -US$27m |
Mar 31 2019 | n/a | n/a | -US$23m |
Dec 31 2018 | US$3m | US$390k | -US$18m |
Sep 30 2018 | n/a | n/a | -US$18m |
Jun 30 2018 | n/a | n/a | -US$18m |
Mar 31 2018 | n/a | n/a | -US$22m |
Dec 31 2017 | US$605k | US$379k | -US$23m |
Compensazione vs Mercato: Robert's total compensation ($USD2.77M) is above average for companies of similar size in the German market ($USD418.12K).
Compensazione vs guadagni: Robert's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Robert Holmlin (55 yo)
12.8yrs
Mandato
US$2,766,572
Compensazione
Dr. Robert Erik Holmlin, Ph D., M.B.A. has been the Chief Executive Officer and President of BioNano Genomics, Inc. (alternatively BioNanomatrix, Inc.) since January 12, 2011 and serves as its Secretary. D...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
President | 12.8yrs | US$2.77m | 0.14% € 66.8k | |
Chief Operating Officer | 6yrs | US$1.50m | 0.47% € 232.2k | |
Chief Medical Officer | 3.3yrs | US$1.32m | 0.0013% € 625.6 | |
Chief Financial Officer | less than a year | Nessun dato | Nessun dato | |
VP of Accounting & Controller | 5.4yrs | Nessun dato | Nessun dato | |
General Counsel | 1.8yrs | Nessun dato | 0.010% € 5.1k | |
Vice President of Global Sales | 1.8yrs | Nessun dato | Nessun dato | |
Global Head of Market Access | less than a year | Nessun dato | Nessun dato | |
Global Head of People Operations | 1.8yrs | Nessun dato | Nessun dato |
1.8yrs
Durata media
49.5yo
Età media
Gestione esperta: 2Y30's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
President | 12.8yrs | US$2.77m | 0.14% € 66.8k | |
Independent Director | 5.3yrs | US$224.42k | 0.017% € 8.4k | |
Independent Chairman of the Board | 13.5yrs | US$249.42k | 0.015% € 7.6k | |
Independent Director | 12.1yrs | US$229.42k | 0% € 0 | |
Independent Director | 3.5yrs | US$211.92k | 0.017% € 8.6k | |
Independent Director | 4.5yrs | US$221.92k | 0% € 0 | |
Independent Director | 3.5yrs | US$209.42k | 0% € 0 | |
Independent Director | 1.9yrs | US$214.42k | 0% € 0 | |
Independent Director | 1.8yrs | US$451.18k | 0% € 0 |
4.5yrs
Durata media
58yo
Età media
Consiglio di amministrazione esperto: 2Y30's board of directors are considered experienced (4.5 years average tenure).